Lung - Cancer
The authors present a robotic-assisted right bilobectomy performed for coexisting right upper lobe bronchiectasis and synchronous middle lobe adenocarcinoma, highlighting the management of dual pathology in the setting of dense inflammatory adhesions. A 45-year-old male...
This case report describes a 75-year-old patient with a centrally located squamous cell carcinoma extending from the carina to the right intermediate bronchus and the superior segment of the lower...
This Society of Thoracic Surgeons General Thoracic Surgery Database analysis found that postoperative chylothorax risk increases with the extent of lymph-node dissection during pulmonary resection. Although uncommon, chylothorax was associated...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...
High tumor mutational burden (TMB) predicts not only response to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) but also immune-related toxicity. In this single-center cohort of...
As a part of Session 1 of the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer, Jonathan Villena-Vargas presented on changes to SLR for lung cancer...
As a part of Session 1 of the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer, Hisao Asamura presented on changes to SLR for lung cancer...
After an introduction giving an overview of the conference by Dominique Gossot, Xavier-Benoit D’Journo, and Isabelle Opitz, the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer...
Sleeve lobectomy is preferred to pneumonectomy for centrally located lung tumors. To report on surgical outcomes of this procedure, The European Society of Thoracic Surgeons database was searched between 2007...
Since time to surgery for lung cancer is not well established, researchers aimed to assess whether time to surgery from diagnosis correlates with outcomes like unplanned return to care, mortality,...
The FDA has approved the drug Cytalux for use in lung surgery. The drug, also known as pafolacianine, binds to lung cancer cells to make them glow under infrared light....
Researchers have been awarded a grant to fund cancer vaccine research, including the development of an mRNA vaccine that would target precancerous lung lesions. Eventually, researchers hope to develop an...
This study aimed to establish risk factors for venous thromboembolism (VTE), a significant cause of mortality in lung cancer surgical patients. Unlike in surgical specialties that have adopted postdischarge VTE...





